Patents Assigned to OptoGenTech GmbH
  • Publication number: 20260137954
    Abstract: An optical cochlea implant has several laser diodes which are assigned to different sound frequencies and several optical wave guides. A controller activates the laser diodes as a function of a signal describing a sound frequency spectrum in order to generate laser light and to couple the laser light into different ones of the optical wave guides which are designed such as to be suitable for guiding the laser light into different light-sensitive areas of a cochlea. The laser diodes are each activated in several separate pulselets, which individually do not result in a neural activation of the respective light-sensitive area of the cochlea. The duty cycles of the pulselets are not more than 25?%; and the pulselets in which different laser diodes are activated are interleaved in such a way that no more than a quarter of the laser diodes are activated simultaneously.
    Type: Application
    Filed: October 23, 2025
    Publication date: May 21, 2026
    Applicants: Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin, OptoGenTech GmbH
    Inventors: Tobias Moser, Lukasz Jablonski, Christian Goßler
  • Patent number: 12612439
    Abstract: The present invention relates to a mutant ion channel capable of being activated by light (‘light-activated’ ion channel) and having improved properties, nucleic acids and expression vectors encoding the mutant ion channel, cells comprising such nucleic acid or expression vector, devices containing the mutant ion channel, nucleic acid or expression vector as well as respective uses and methods.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: April 28, 2026
    Assignees: GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS, UNIVERSITÄTSMEDIZIN, OPTOGENTECH GMBH
    Inventors: Tobias Moser, Thomas Mager, Maria Zerche
  • Publication number: 20230250143
    Abstract: The present invention relates to a mutant ion channel capable of being activated by light (‘light-activated’ ion channel) and having improved properties, nucleic acids and expression vectors encoding the mutant ion channel, cells comprising such nucleic acid or expression vector, devices containing the mutant ion channel, nucleic acid or expression vector as well as respective uses and methods.
    Type: Application
    Filed: February 3, 2023
    Publication date: August 10, 2023
    Applicants: Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin, OptoGenTech GmbH
    Inventors: Tobias MOSER, Thomas MAGER, Maria ZERCHE